On August 3, 2015, Aprecia Phramaceuticals, announced that the U.S. Food and Drug Administration (FDA) approved itâs SPRITAM drug for the treatment of epilepsy. The company claims that SPRITAM is the first drug ever approved by the FDA that is manufactured using 3-D printing technologies. Aprecia Pharmaceuticals announced that its epilepsy drug SPRITAM was the first drug approved by the FDA that is manufactured with 3-D printing technologies. (Image Credit: Aprecia Pharmaceuticals) âBy combining 3-D printing technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,â said Don Wetherhold, Aprecia CEO.
Autistic disorder, sometimes called autism or classical ASD, is the most severe form of ASD, while other conditions along the spectrum include a milder form known as Asperger syndrome, and childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (usually referred to as PDD-NOS).utistic disorder, sometimes called autism or classical ASD, is the most severe form of ASD, while other conditions along the spectrum include a milder form known as Asperger syndrome, and childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (usually referred to as PDD-NOS).
Bipolar disorder is a serious mental illness characterized by recurrent episodes of depression, mania, and/or mixed symptom states. These episodes cause unusual and extreme shifts in mood, energy, and behavior that interfere significantly with normal, healthy functioning.